New therapies for autoimmune myasthenia gravis: vol 22, pg 368, 2023

Author(s):
Verschuuren, J.
Published
2023
Publication type
Article / Letter to editor

Abstract

Verschuuren J. New therapies for autoimmune myasthenia gravis. Lancet Neurol 2023; 22: 368–69—In this Comment, the drug rozanolixizumab was misspelled twice. This correction has been made to the online version as of May 18, 2023.

Date issued
2023-06-30
Language
English
Publisher
Elsevier
Is part of
The Lancet Neurology (2023), Vol. 22, no. 6, p. E8-E8
hdl
1887/4248808
doi
10.1016/S1474-4422(23)00173-4
URL
https://www.sciencedirect.com/science/article/pii/S1474442223001734?via%3Dihub